Discussed in
// RECENT MENTIONS
// SIGNALS
5 SIGNALS
01
funding·Axios Pro Rata·OCTOBER 15, 2026
“OrbiMed raised $1.9b for its tenth flagship VC fund and over $1b for its sixth Asia-focused VC and PE fund.”
02
m_and_a·PitchBook News·OCTOBER 6, 2026
“CSL agreed to a $1.6 billion deal with OrbiMed-backed Alentis Therapeutics to develop a drug for rare kidney and liver diseases.”
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.